Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Reverso

K-Number: K212107 · 2021-11-10

Decision Date2021-11-10
Product CodeGEI
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

Reverso is a medical device manufactured by Intelis Instruments , Ltd.. It received FDA 510(k) clearance on 2021-11-10 under approval number K212107. The device is classified under product code GEI. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Reverso?

Reverso is a medical device that received FDA 510(k) clearance on 2021-11-10. It is manufactured by Intelis Instruments , Ltd.. The 510(k) number is K212107.

When was Reverso approved by the FDA?

Reverso received FDA 510(k) clearance on 2021-11-10, under approval number K212107.

What company makes Reverso?

Reverso is manufactured by Intelis Instruments , Ltd..

What is the FDA product code for Reverso?

The FDA product code for Reverso is GEI.

Related Devices (Code: GEI)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.